Review of delta‐8‐tetrahydrocannabinol (Δ8‐THC): Comparative pharmacology with Δ9‐THC von Tagen, Michael, Klumpers, Linda E.

Volltext

Peripheral selectivity of the novel cannabinoid receptor antagonist TM38837 in healthy subjects von Klumpers, Linda E., Fridberg, Marianne, Kam, Marieke L., Little, Paul B., Jensen, Niels Ole, Kleinloog, Hendrik D., Elling, Christian E., Gerven, Joop M. A.

Volltext

Review of delta-8-tetrahydrocannabinol (Δ 8 -THC): Comparative pharmacology with Δ 9 -THC von Tagen, Michael, Klumpers, Linda E

Volltext

A Brief Background on Cannabis: From Plant to Medical Indications von Klumpers, Linda E, Thacker, David L

Volltext

Pharmacokinetics of Two Nanoemulsion Formulations of Δ8-Tetrahydrocannabinol in Rats von Tagen, Michael, Klumpers, Linda E., Peshkovsky, Alexey

Volltext

The risk of chronic psychedelic and MDMA microdosing for valvular heart disease von Tagen, Michael, Mantuani, Daniel, van Heerden, Liron, Holstein, Alex, Klumpers, Linda E., Knowles, Richard

Volltext

Cannabidiol Increases Psychotropic Effects and Plasma Concentrations of Δ9‐Tetrahydrocannabinol Without Improving Its Analgesic Properties von Gorbenko, Andriy A., Heuberger, Jules A.A.C., Klumpers, Linda E., Kam, Marieke L., Strugala, Pamela K., Visser, Saco J., Groeneveld, Geert J.

Volltext

Cannabidiol Increases Psychotropic Effects and Plasma Concentrations of Δ 9 -Tetrahydrocannabinol Without Improving Its Analgesic Properties von Gorbenko, Andriy A, Heuberger, Jules A A C, Klumpers, Linda E, de Kam, Marieke L, Strugala, Pamela K, de Visser, Saco J, Groeneveld, Geert J

Volltext

Novel Δ(9) -tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects von Klumpers, Linda E, Beumer, Tim L, van Hasselt, Johan G C, Lipplaa, Astrid, Karger, Lennard B, Kleinloog, H Daniël, Freijer, Jan I, de Kam, Marieke L, van Gerven, Joop M A

Volltext

Pharmacokinetic/pharmaco-dynamic modelling and simulation of the effects of different cannabinoid receptor type 1 antagonists on Δ(9)-tetrahydrocannabinol challenge tests von Guan, Zheng, Klumpers, Linda E, Oyetayo, Olubukayo-Opeyemi, Heuberger, Jules, van Gerven, Joop M A, Stevens, Jasper

Volltext

Manipulating brain connectivity with δ9-tetrahydrocannabinol: A pharmacological resting state FMRI study von Klumpers, Linda E., Cole, David M., Khalili-Mahani, Najmeh, Soeter, Roelof P., te Beek, Erik T., Rombouts, Serge A.R.B., van Gerven, Joop M.A.

Volltext

Surinabant, a selective cannabinoid receptor type 1 antagonist, inhibits Δ9‐tetrahydrocannabinol‐induced central nervous system and heart rate effects in humans von Klumpers, Linda E., Roy, Christine, Ferron, Geraldine, Turpault, Sandrine, Poitiers, Franck, Pinquier, Jean‐Louis, Hasselt, Johan G. C., Zuurman, Lineke, Erwich, Frank A. S., Gerven, Joop M. A.

Volltext

Surinabant, a selective cannabinoid receptor type 1 antagonist, inhibits Δ 9 ‐tetrahydrocannabinol‐induced central nervous system and heart rate effects in humans von Klumpers, Linda E., Roy, Christine, Ferron, Geraldine, Turpault, Sandrine, Poitiers, Franck, Pinquier, Jean‐Louis, van Hasselt, Johan G. C., Zuurman, Lineke, Erwich, Frank A. S., van Gerven, Joop M. A.

Volltext

Pharmacokinetics of Two Nanoemulsion Formulations of Δ 8 -Tetrahydrocannabinol in Rats von Tagen, Michael, Klumpers, Linda E, Peshkovsky, Alexey

Volltext

Novel Δ9‐tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects von Klumpers, Linda E., Beumer, Tim L., van Hasselt, Johan G. C., Lipplaa, Astrid, Karger, Lennard B., Kleinloog, H. Daniël, Freijer, Jan I., de Kam, Marieke L., van Gerven, Joop M. A.

Volltext

Pharmacokinetic/pharmaco–dynamic modelling and simulation of the effects of different cannabinoid receptor type 1 antagonists on Δ 9 ‐tetrahydrocannabinol challenge tests von Guan, Zheng, Klumpers, Linda E., Oyetayo, Olubukayo‐Opeyemi, Heuberger, Jules, van Gerven, Joop M. A., Stevens, Jasper

Volltext

Pharmacokinetic/pharmaco–dynamic modelling and simulation of the effects of different cannabinoid receptor type 1 antagonists on Δ9‐tetrahydrocannabinol challenge tests von Guan, Zheng, Klumpers, Linda E., Oyetayo, Olubukayo‐Opeyemi, Heuberger, Jules, Gerven, Joop M. A., Stevens, Jasper

Volltext

Peripheral selectivity of the novel cannabinoid receptor antagonist TM 38837 in healthy subjects von Klumpers, Linda E., Fridberg, Marianne, de Kam, Marieke L., Little, Paul B., Jensen, Niels Ole, Kleinloog, Hendrik D., Elling, Christian E., van Gerven, Joop M. A.

Volltext

Manipulating brain connectivity with [delta]9-tetrahydrocannabinol: A pharmacological resting state FMRI study von Klumpers, Linda E, Cole, David M, Khalili-Mahani, Najmeh, Soeter, Roelof P, te Beek, Erik T, Rombouts, Serge ARB, van Gerven, Joop MA

Volltext

Novel Δ 9 ‐tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects von Klumpers, Linda E., Beumer, Tim L., van Hasselt, Johan G. C., Lipplaa, Astrid, Karger, Lennard B., Kleinloog, H. Daniël, Freijer, Jan I., de Kam, Marieke L., van Gerven, Joop M. A.

Volltext